Cortisol dysregulation

What it is

Cortisol dysregulation is a disruption in the normal production or daily rhythm of cortisol—the body's primary stress hormone—that affects energy, mood, metabolism, immune function, and sleep across multiple body systems. Also called hypothalamic-pituitary-adrenal (HPA) axis dysfunction, it is not a single diagnosis but a spectrum of clinical states ranging from mild rhythm disturbances to severe hormonal excess or deficiency. Cortisol is produced by the adrenal glands in response to signals from the hypothalamus and pituitary gland via the HPA axis. Under normal conditions it follows a distinct diurnal rhythm: it peaks sharply within 30–45 minutes of waking, then declines steadily, reaching its lowest point around midnight. When that rhythm breaks down—through chronic stress, poor sleep, shift work, trauma, or underlying disease—the consequences extend well beyond fatigue.

At the extreme ends of the spectrum sit two recognized medical diagnoses: Cushing's syndrome (severe, sustained cortisol excess, affecting roughly 10–15 people per million annually) and Addison's disease (primary adrenal insufficiency, affecting approximately 1 in 10,000 Canadians). Between these poles lies a broader range of subtler dysregulation patterns seen in burnout, chronic fatigue syndrome, post-traumatic stress disorder (PTSD), and metabolic syndrome—states where cortisol levels or timing are measurably abnormal but do not meet criteria for either extreme diagnosis.

Pattern	Cortisol level	Common associations
Chronic elevation	Persistently high	Psychological stress, Cushing's syndrome, obstructive sleep apnea, long-term glucocorticoid use
HPA blunting	Low or flat diurnal curve	Burnout, PTSD, prolonged chronic stress, overtraining
Addison's disease	Deficient at all times	Autoimmune adrenal destruction
Disrupted timing	Normal total output, wrong schedule	Shift work, jet lag, irregular sleep-wake cycles

Causes and mechanism

The HPA axis operates through a feedback loop: the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary to release adrenocorticotropic hormone (ACTH), which in turn drives cortisol secretion from the adrenal cortex. Elevated cortisol then feeds back to suppress further CRH and ACTH release. Dysregulation occurs when this loop is chronically over-activated, blunted, or structurally damaged.

Causes of elevated cortisol include persistent psychological stress (the most common driver in primary care), pituitary or adrenal tumours causing Cushing's syndrome, long-term glucocorticoid medications such as prednisone, and obstructive sleep apnea—where repeated overnight oxygen drops repeatedly trigger the stress response.

Causes of low or blunted cortisol include prolonged chronic stress that eventually exhausts HPA responsiveness, autoimmune destruction of the adrenal cortex (Addison's disease), PTSD (associated with consistently low morning cortisol and heightened reactivity to specific triggers), and nutritional deficiencies in vitamin C, B vitamins, and magnesium, all of which are required for adrenal steroid synthesis.

Symptoms and diagnosis

Symptoms differ depending on whether cortisol is running too high, too low, or is dysregulated in its timing.

High cortisol typically presents with abdominal and facial weight gain, elevated blood pressure and fasting glucose, poor sleep with difficulty switching off at night, anxiety, irritability, and—in prolonged cases—skin thinning, easy bruising, and poor wound healing.

Low or blunted cortisol typically presents with profound morning fatigue that does not improve with rest, low blood pressure, dizziness on standing (orthostatic hypotension), salt and sugar cravings, low mood, emotional flatness, and poor stress tolerance.

Disrupted timing without extreme levels often produces the characteristic pattern of feeling wired at night and exhausted in the morning, with an energy crash in the early afternoon.

Clinicians in Canada can investigate cortisol dysregulation through several tests available at LifeLabs and Dynacare:

1. Morning serum cortisol (8 a.m.) — assesses the peak of the normal diurnal rhythm
2. 24-hour urinary free cortisol — captures total daily output
3. ACTH stimulation test — evaluates adrenal reserve and rules out Addison's disease
4. Salivary cortisol at multiple time points — maps the full diurnal curve including morning peak, afternoon level, and nighttime nadir
5. Low-dose dexamethasone suppression test — screens for Cushing's syndrome

Treatment options

Treatment depends on the direction and cause of the dysregulation.

For high cortisol driven by chronic stress, first-line approaches are lifestyle-based: cognitive behavioural therapy (CBT), mindfulness-based stress reduction (MBSR), and regular moderate-intensity exercise all have consistent evidence for lowering cortisol over time and improving HPA regulation. Restoring consistent, high-quality sleep is equally important, since sleep disruption and cortisol elevation reinforce each other. Where an underlying medical cause exists—Cushing's syndrome, untreated sleep apnea, or unnecessary long-term glucocorticoid use—treating that cause is the priority.

For low or blunted cortisol, the focus is on resolving root causes: treating chronic infections, correcting nutritional deficiencies, addressing sleep disorders, and reducing training load in athletes. Adaptogenic herbs such as ashwagandha and rhodiola have some evidence for supporting HPA axis regulation in subclinical low-cortisol states, though the evidence base remains limited. Confirmed adrenal insufficiency (Addison's disease) requires hydrocortisone replacement therapy, which is available by prescription across Canadian provinces and is covered under most provincial drug benefit programs.

For disrupted cortisol timing, circadian rhythm optimization is the primary tool: consistent sleep-wake times, morning bright-light exposure (ideally 10–30 minutes of natural light within an hour of waking), and reducing blue-light exposure in the 2 hours before bed help re-anchor the cortisol awakening response.

Canadian patients seeking assessment and management can access care through their family physician, an endocrinologist via referral, or through virtual hormone health platforms such as Felix, Cleo, Phoenix, Maple, or Science & Humans—though the scope of testing and prescribing varies by platform.

When to see a clinician in Canada

See a physician promptly if you notice unexplained weight gain concentrated around the abdomen or face, new purple stretch marks on the abdomen, or easy bruising—these may indicate Cushing's syndrome and warrant specialist referral. Persistent low blood pressure, dizziness on standing, and extreme fatigue alongside salt cravings are potential signs of adrenal insufficiency and should be investigated with an ACTH stimulation test. Fatigue that does not improve after 4–6 weeks of consistent sleep and stress management, or mood and cognitive changes that are worsening progressively under sustained stress, are also reasonable triggers for a cortisol workup. Patients who have been on corticosteroid medications (prednisone, dexamethasone, or inhaled steroids at high doses) for more than a few weeks should discuss HPA suppression with their prescriber before stopping.

Limitations and open questions

Research is still emerging on the precise thresholds that distinguish clinically significant HPA blunting from normal variation. "Adrenal fatigue" as a distinct diagnosis is not recognized by the Endocrine Society, the Society of Obstetricians and Gynaecologists of Canada (SOGC), or Health Canada—the underlying symptom pattern is real, but the label lacks validated diagnostic criteria and standardized treatment protocols. Salivary cortisol testing, while useful for mapping diurnal rhythm, is not yet uniformly standardized across Canadian laboratories, and reference ranges vary between collection methods. The long-term efficacy of adaptogenic supplements for HPA dysregulation has not been evaluated in large randomized controlled trials. Health Canada has not issued specific guidance on subclinical cortisol dysregulation outside of recognized adrenal disease, meaning management decisions in this grey zone rely heavily on clinician judgment and emerging research rather than formal guidelines.